Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
4.50
Dollar change
+0.39
Percentage change
9.49
%
IndexRUT P/E- EPS (ttm)-0.05 Insider Own3.78% Shs Outstand270.03M Perf Week26.76%
Market Cap1.22B Forward P/E19.58 EPS next Y0.23 Insider Trans-2.21% Shs Float260.19M Perf Month34.73%
Income-11.94M PEG- EPS next Q0.12 Inst Own49.46% Short Float13.32% Perf Quarter27.12%
Sales198.96M P/S6.12 EPS this Y535.42% Inst Trans8.30% Short Ratio12.65 Perf Half Y-5.06%
Book/sh-0.91 P/B- EPS next Y31.96% ROA-3.10% Short Interest34.65M Perf Year-6.83%
Cash/sh1.09 P/C4.12 EPS next 5Y35.60% ROE- 52W Range3.17 - 5.75 Perf YTD23.63%
Dividend Est.- P/FCF- EPS past 5Y40.58% ROI-11.45% 52W High-21.74% Beta1.27
Dividend TTM- Quick Ratio3.31 Sales past 5Y55.42% Gross Margin68.45% 52W Low41.96% ATR (14)0.22
Dividend Ex-Date- Current Ratio3.59 EPS Y/Y TTM86.73% Oper. Margin5.32% RSI (14)76.17 Volatility8.58% 5.16%
Employees414 Debt/Eq- Sales Y/Y TTM99.42% Profit Margin-6.00% Recom1.33 Target Price6.92
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q106.31% Payout- Rel Volume2.56 Prev Close4.11
Sales Surprise8.40% EPS Surprise-100.00% Sales Q/Q62.16% EarningsFeb 27 AMC Avg Volume2.74M Price4.50
SMA2025.82% SMA5026.61% SMA20011.03% Trades Volume7,001,804 Change9.49%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Feb-28-24 09:30AM
08:11AM
01:00AM
Feb-27-24 06:00PM
05:35PM
04:46PM Loading…
04:46PM
04:00PM
Feb-20-24 06:00AM
Feb-15-24 06:05AM
Feb-12-24 12:30PM
Jan-25-24 05:29PM
Jan-02-24 06:05AM
Dec-28-23 06:00AM
Dec-16-23 09:01PM
Nov-08-23 03:27PM
09:15PM Loading…
Nov-07-23 09:15PM
05:30PM
04:12PM
04:00PM
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
Oct-30-23 06:15AM
Sep-07-23 07:08AM
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
11:33AM
12:00AM
06:00PM Loading…
Aug-07-23 06:00PM
05:25PM
04:16PM
04:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
07:00AM
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
06:00AM
May-09-23 11:30PM
08:21PM
05:15PM
04:18PM
04:00PM
01:41PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
05:31AM
Nov-08-22 04:30PM
09:15AM
08:00AM
Nov-01-22 06:00AM
Sep-29-22 11:38AM
06:13AM
Sep-21-22 05:00PM
Sep-19-22 06:00AM
Sep-08-22 01:18PM
Sep-06-22 06:15AM
Sep-01-22 06:00AM
Aug-25-22 09:09AM
Aug-19-22 06:18AM
Aug-16-22 09:03AM
Aug-10-22 07:19AM
05:30AM
Aug-09-22 05:15PM
05:00PM
04:00PM
Aug-02-22 06:00AM
Aug-01-22 07:35PM
06:00AM
Jul-26-22 10:13AM
Jun-20-22 09:28AM
07:22AM
Jun-03-22 10:00AM
May-25-22 10:16AM
May-24-22 06:00AM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Castagna MichaelChief Executive OfficerDec 15Sale4.0090,482361,9282,148,665Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerDec 14Sale4.00110,000440,0002,239,147Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerNov 01Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01Sale4.5710,00045,6862,496,735Aug 01 09:00 PM
Castagna MichaelChief Executive OfficerJul 03Sale4.0710,00040,7012,506,735Jul 05 06:00 AM
Castagna MichaelChief Executive OfficerJun 01Sale4.5310,00045,3022,516,735Jun 02 09:00 PM
Castagna MichaelChief Executive OfficerMay 26Sale4.5075,000337,3352,526,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 25Sale4.5975,000344,4682,601,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 24Sale4.69150,000702,7802,331,735May 24 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 24Sale4.6895,576447,754735,263May 24 09:00 PM
Binder Steven B.Chief Financial OfficerMay 24Sale4.6747,810223,512838,324May 24 09:00 PM
Castagna MichaelChief Executive OfficerMay 05Sale4.0010,00040,0002,020,128May 05 09:00 PM
Castagna MichaelChief Executive OfficerApr 03Sale4.1310,00041,2872,030,128Apr 05 09:00 PM